You are here: Industry Insights > Series B financing

News List

Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines prnasia
July 01, 2021
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced that it has raised $73M in Series B financing.
Puyi Biotechnology Completes Series B Financing prnasia
June 02, 2021
Puyi (Shanghai) Biotechnology Co., Ltd. recently announced the completion of its Series B financing led by Goldman Sachs Asset Management. The proceeds will be used to further augment R&D and business development.
Genesis MedTech Group Raises Significant Growth Investment in Latest Round of Series B Financing prnasia
May 24, 2021
Genesis MedTech Group, a leading medical device company, announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital ...
Duality Biologics Completed $90 Million Series B Financing prnasia
May 20, 2021
Duality Biologics, an innovative biotech company, announced the completion of $90 million series B financing today. This round of financing was led by Lilly Asia Ventures (LAV) and jointly invested by YUNION Healthcare Fund, Huagai Capital ...
Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation prnasia
May 06, 2021
Recently, the global innovative drug R&D company Hope Medicine Inc. announced the completion of a Series B financing US$56 million. This round of financing was jointly led by Qiming Venture Partners and Grand Flight Investment. HighLight Capital (HLC) ...
AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline prnasia
March 30, 2021
AffaMed Therapeutics, a global clinical-stage biopharmaceutical company dedicated to addressing critical unmet patient need in ophthalmic, neurological and psychiatric disorders, today announced the completion of over US$170 million in Series B financing.
Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies prnasia
March 25, 2021
Bioheng Biotech Co., Ltd, a clinical-stage biotechnology company dedicated on developing novel cellular immunotherapy for cancer, today announced that it had secured $80 million in Series B Financing.
Regor Therapeutics Announces Completion of $90 Million Series B Financing prnasia
February 19, 2021
Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing.
Sciwind Biosciences Secures US$37 Million Series B Financing prnasia
February 19, 2021
Hangzhou Sciwind Biosciences Co., Ltd. (Sciwind), a clinical-stage, fast-growing biopharmaceutical company focusing on research and development of innovative biologics, today announced the closing of an US$37 Million series B financing.
Neurophth Closes RMB 400 Million Series B Financing prnasia
February 10, 2021
Neurophth Biotechnology Ltd. announced the closing of a RMB 400 million ($61.9 million USD) Series-B financing with a premier syndicate of investors, co-led by Guofang Capital and InnoVision Capital.

Previous page 1 2 3 Next page